MRC1 and breast carcinoma: Four patients with a suggestive clinical phenotype but without mutations found on the DNA panel were tested: one patient showed a severe breast cancer family and three patients developed Lynch syndrome spectrum tumors with protein expression profiles suggestive of a mutation in an MMR gene.